Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

A Two-Part Study to Assess the Effectiveness, Safety, and Blood Levels of Repeat Doses of Inhaled ETD001 in People with Cystic Fibrosis Ended

2023-504092-25-00 Cystic Fibrosis 4 2024-06-04
A study on the immune response and safety of vaccine against respiratory syncytial virus given to adults 18 to 49 years of age at increased … Ended

2023-510190-34-00 Respiratory Syncytial Virus Infections 5 2024-06-04
Phase 2 study comparing SAR447537 to plasma-derived A1PI therapy for AATD emphysema Ended

2023-508084-76-00 Alpha-1 Antitrypsin Deficiency (AATD) Emphysema 4 2024-05-31
A Phase IIb, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Po… Ended

2022-500410-26-01 Cystic Fibrosis 4 2024-05-27
A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Ended

2022-502481-24-00 Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) 4 2024-05-23
A study to compare the pharmacokinetics of salbutamol administered via metered dose inhalers containing propellants HFA-152a (test) or HFA-1… Ended

2023-508279-36-00 Healthy volunteers 3 2024-05-22
A Phase 1/2 Study of TAS3351 in Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutations Ended

2022-502595-23-00 Patients with locally advanced or metastatic non-small 7 2024-05-21
Phenosar Ended

2024-513534-38-00 sarcoidosis 6 2024-05-13
Maternal pertussis immunization in Finland, 4 years (MIFI-4Y) Ended

2024-510787-23-00 Pertussis 6 2024-05-07
Safety and tolerability of single and multiple ascending doses of lunsekimig (SAR443765) in healthy participants Ended

2023-509316-28-00 Asthma 3 2024-05-06
Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-res… Ended

2023-503256-27-00 patients with cystic fibrosis suffering from pancreatic 3 2024-04-18
A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) Ended

2023-503693-20-01 Severe eosinophilic asthma 5 2024-04-10
Effect of Erythromycin on the absorption, metabolism and elimination of CHF6001 in healthy volunteers Ended

2023-507300-30-00 This study is a phase I trial to investigate the effec 3 2024-03-27
A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab via Subcutaneous Administration in Healthy Vol… Ended

2023-508041-40-00 healthy volunteers 3 2024-03-19
Randomised, relative bioavailability clinical trial of amylmetacresol, dichlorobenzyl alcohol, lidocaine and vitamin c lozenges after a sing… Ended

2023-507599-34-00 healthy volunteer 2 2024-03-11
Study Drug vs Placebo as an “add on” treatment for Severe Community-Acquired Pneumonia. Ended

2023-505985-28-01 Severe Community-Acquired Pneumonia 4 2024-03-04
A study to test how well BI 1291583 is tolerated by people with cystic fibrosis bronchiectasis (ClairaflyTM) Ended

2022-502835-21-00 cystic fibrosis bronchiectasis 4 2024-02-23
A clinical study for patients with newly diagnosed, locally advanced non-small cell lung cancer (NSCLC) with a change in the ALK-gene, to te… Ended

2022-502467-38-00 Non-small cell lung cancer (NSCLC) 4 2024-02-22
Using live vaccines to induce beneficial innate immune training and reduce systemic inflammation in COPD patients Ended

2023-504519-34-01 Chronic obstructive pulmonary disease 4 2024-02-22
Randomized, controlled, open-label, multi-center trial to compare the efficacy and safety of three herbal medicinal products in the treatmen… Ended

2023-507370-41-00 Acute bronchitis 6 2024-02-14
"Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations (MIRANDA)" Ended

2023-505543-39-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-02-12
THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICA… Ended

2023-507304-32-00 Chronic Obstructive Pulmonary Disease 6 2024-02-09
Evaluation of the effect of CHF6795 on the pharmacokinetics of midazolam, repaglinide and rosuvastatin in healthy subjects Ended

2023-507997-41-00 Chronic cough 3 2024-01-25
A 12-week double-blind, multicentre, randomised, active-controlled, 2-arm, parallel-group clinical trial to evaluate the safety of CHF5993 p… Ended

2023-503333-22-00 Moderate to severe controlled asthma according to Step 5 2024-01-15